U.S. Professional Services Stock News

If you are wondering whether West Pharmaceutical Services is fairly priced or offering value right now, looking at a clear, structured view of its valuation can help you decide how it fits into your watchlist. The share price closed at US$248.95, with a 7.7% gain over the last 7 days, while the 1 year return sits at a 22.3% decline and the year to date return is a 9.9% decline. Over the past month, the stock recorded a 9.6% decline, and over 3 and 5 year periods the returns are 7.4% and...

If you are wondering whether Utz Brands at around US$10.98 is a bargain or fairly priced, this article will walk you through what the current share price might be implying. The stock has posted a 4.2% return over the last week and 10.5% over the last month, although it still shows a 6.7% return year to date and a 16.2% decline over the last year, extending to a 29.1% decline over three years and 53.6% over five years. Recent coverage of Utz Brands has focused on the company as a listed snack...

First Financial Bancorp. recently reported its fourth quarter and full-year 2025 results, showing higher net interest income year on year and full-year net income of US$255.61 million, while also affirming a US$0.25 quarterly dividend and reducing net charge-offs compared with the prior year period. Alongside these results, the bank filed a US$79.29 million shelf registration for 2,753,094 common shares and continued integrating the Westfield acquisition, which boosted deposits and fee...

Tompkins Financial Corporation reported past fourth-quarter and full-year 2025 results showing higher net interest income and net income versus 2024, with basic earnings per share from continuing operations rising to US$6.74 for the quarter and US$11.30 for the year. Alongside these stronger earnings, the company raised its regular quarterly dividend to US$0.67 per share and completed a small share repurchase program, highlighting a continued focus on returning cash to shareholders despite...

If you are wondering whether Arm Holdings' recent share price puts it at a fair level or not, this article will walk through what that current price might mean for value focused investors. The stock recently closed at US$123.70, with returns of 17.4% over the last 7 days and 10.7% over the last 30 days, while the 1 year return sits at a 23.9% decline and the year to date return is 7.8%. Recent news flow around Arm has centered on its position in semiconductor design, licensing and ecosystem...

If you are looking at Curtiss-Wright and wondering whether the current share price gives you good value, this article will walk you through what the numbers are actually saying. The stock last closed at US$649.32, with returns of 7.3% over the past 30 days, 13.4% year to date, 83.3% over 1 year and a very large gain over 5 years that is just under 5x. Recent interest in Curtiss-Wright has been shaped by ongoing attention on companies in capital goods and defense related markets, as investors...

Niagen Bioscience, Inc. (NASDAQ: NAGE) previously announced it will report fourth quarter and fiscal 2025 results and host an investor conference call on March 4, 2026, including a general business update following the release of its earnings after market close. The company’s position as a leading NAD+ player, with FDA-recognized Niagen® and defended patents around nicotinamide riboside, highlights a reinforced regulatory moat and product pipeline momentum. We’ll now examine how the upcoming...

Wondering if Post Holdings at around US$114.61 is offering fair value or a potential bargain, especially after its recent run, is a natural question for anyone watching the stock. The share price performance has been strong recently, with returns of 12.0% over the last 7 days, 15.7% over the last 30 days, 15.0% year to date and 68.0% over 5 years. The 1 year return stands at 1.8% and the 3 year return at 24.9%. Recent attention on Post Holdings has centered on its position within the...

Donaldson Company (NYSE:DCI) named COO Richard Lewis as its next CEO, succeeding retiring CEO Tod Carpenter. The leadership transition follows Carpenter’s extensive tenure and is set to take effect alongside his retirement. Donaldson also agreed to acquire Facet Filtration for $820 million, adding to its filtration offerings. The combination of the CEO handover and the Facet Filtration deal marks a significant corporate update for the company. For investors tracking Donaldson Company at a...

Earlier this week, Broadcom announced the industry's first Wi‑Fi 8 access point and switch solution built on its new BCM49438 APU and Trident X3+ BCM56390 Ethernet switch, aiming to support AI-ready enterprise networks with unified security, analytics, and multi-gigabit performance. An interesting angle is that this enterprise Wi‑Fi 8 launch sits alongside surging AI data-center demand from hyperscalers like Alphabet and Amazon, positioning Broadcom across both cloud AI accelerators and the...

Why Perella Weinberg Partners Has Caught Investor Attention Perella Weinberg Partners (PWP) has been drawing fresh interest from investors after a strong recent share price move, with the stock up around 8% over the past week and about 23% over the past month. See our latest analysis for Perella Weinberg Partners. The latest 1 day share price return of 8.0% continues a run that has lifted the 30 day share price return to 23.4% and the year to date share price return to 32.5%. The 3 year total...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Newell Brands has reduced its sourcing exposure to China, shifting its supply chain footprint. The company is rolling out automation and AI tools to improve productivity across its global operations. Management is resetting pricing after some customers pushed back on previous price levels. Newell Brands recorded a substantial impairment of acquired intangible assets in its latest quarter. Newell Brands (NasdaqGS:NWL) is making these changes while its shares trade at $4.63. The stock is up...

If you are wondering whether Medical Properties Trust at around US$5.36 is a potential bargain or a value trap, you are not alone. A closer look at its valuation can help you frame that question more clearly. The stock is up 6.8% over the last 7 days and 5.5% year to date. That sits against a 20.0% return over 1 year and much larger declines of 41.4% over 3 years and 64.1% over 5 years. Recent news around Medical Properties Trust has largely focused on its balance sheet strength, asset...

If you are wondering whether Hershey at around US$231.53 is still reasonable value after a strong run, this article walks through the key numbers that matter. The stock has recent returns of 18.9% over 7 days, 22.5% over 30 days, 26.9% year to date and 54.3% over 1 year, which naturally raises questions about how the current price lines up with the fundamentals. Recent news coverage has focused on Hershey as a long established consumer brand, with attention on how staple food companies are...

If you are wondering whether Bausch Health Companies at around US$5.88 is a bargain or a value trap, you are not alone. This article is built to help you weigh that up with a clear look at the numbers. The stock has seen mixed recent returns, with a 2.4% gain over the last 7 days, a 20.6% decline over the past month, and returns of 18.4% lower year to date and 8.8% lower over the past year, set against a much steeper 81.2% decline over five years. Recent news coverage around Bausch Health...

Recent news highlighted how U.S. government initiatives such as Project Vault and possible Defense Production Act support are boosting attention on TMC The Metals Company’s deep-sea polymetallic nodule mining plans, alongside new funding including a US$37 million direct investment and a US$85.2 million strategic commitment from Korea Zinc. This combination of policy momentum and fresh capital underscores TMC’s role in efforts to secure alternative battery metal supplies and reduce reliance...

DoubleVerify Holdings (DV) came under pressure after new generative AI models from Anthropic and OpenAI showed they can automate complex software auditing and code management, prompting investors to reassess potential long term demand for some enterprise software offerings. See our latest analysis for DoubleVerify Holdings. Beyond the latest AI concerns, DoubleVerify’s share price has been weak for some time, with a 7 day share price return of 13.68% and a 1 year total shareholder return...

Wondering if Antero Midstream at around US$19.18 is offering fair value or if the market is missing something? This article walks through the key signals that matter for you. The stock has recent returns of 1.9% over 7 days, 10.8% over 30 days, 6.9% year to date, 25.4% over 1 year, 116.4% over 3 years and 205.3% over 5 years, which gives useful context before you weigh up what you are paying today. Recent attention on Antero Midstream has focused on its role as an energy infrastructure...

Jazz Pharmaceuticals (NasdaqGS:JAZZ) is back in focus after practice changing HERIZON GEA trial results and plans to file a supplemental Biologics License Application in 2026 for first line gastroesophageal adenocarcinoma therapies. See our latest analysis for Jazz Pharmaceuticals. Investors have responded positively to the HERIZON GEA update, with a 24.26% 90 day share price return from Jazz Pharmaceuticals and a 37.58% 1 year total shareholder return, suggesting momentum has picked up...

Why Relay Therapeutics (RLAY) is on investors’ radar Relay Therapeutics (RLAY) has drawn attention after a strong stretch of share price performance, including a positive move over the past month and an even stronger gain in the past 3 months. See our latest analysis for Relay Therapeutics. At a latest share price of $8.92, Relay Therapeutics has seen momentum build, with a 1 day share price return of 9.45% and a 90 day share price return of 44.57%, while the 1 year total shareholder return...

Ermenegildo Zegna (ZGN) is back in focus after reporting unaudited fourth quarter and full year 2025 revenues and receiving an upgrade from UBS, which has drawn fresh attention to the company’s recent operating trends. See our latest analysis for Ermenegildo Zegna. The latest unaudited revenue update and the UBS upgrade have come alongside a sharp rebound in sentiment, with a 7 day share price return of 19.56% and a 1 year total shareholder return of 20.47%. This suggests momentum has...

Popular, Inc. recently reported full-year 2025 results showing higher net interest income of US$2,541.2 million and net income of US$833.16 million, and it also disclosed lower quarterly net charge-offs alongside ongoing preferred and trust preferred dividend payments. The company further reinforced shareholder returns by completing a share repurchase of 1,847,274 shares for US$218.83 million while continuing regular income distributions on its hybrid securities. With earnings strength and...

Banc of California, Inc.'s ( NYSE:BANC ) periodic dividend will be increasing on the 1st of April to $0.12, with...